September is National Cholesterol Education Month and is the perfect time to find out your cholesterol levels and take steps to prevent or reduce high cholesterol. High cholesterol is a significant ...

September is National Cholesterol Education Month, and health experts are urging people to pay attention to what they call a “silent risk”: high levels of LDL, often referred to as “bad cholesterol.” ...

A new FDA-approved daily pill aimed at lowering “bad” cholesterol is drawing attention from doctors and patients looking for another option to bring down high LDL levels. The drug is called Lipfendra, ...

HYDERABAD, India, Aug. 27, 2026 /PRNewswire/ -- What if gaining a better understanding of your everyday wellness began simply with placing your thumbs on a device for 60 seconds? This is the powerful ...

I’ve received so many questions from readers, clients and a few family members about the recently updated guidelines from the American College of Cardiology and the American Heart Association on ...

Ignite Cycle Executive Director Amy Stanaland, left, and The Wellness Passport Owner Emma Riley, right, are pumped to kick off the 2026 season for The Wellness Passport, with passports on sale now.

As you visit the doctor over the years, you may notice certain numbers in your bloodwork slowly creeping up. Cholesterol, a waxy substance found in every cell of your body, is vital to its functioning ...

"Looking ahead to next quarter, we're expecting a 2% to 4% top line growth" (CFO Nemchenko). Nemchenko said the outlook is "driven by the ramp-up of new store openings and our M&A pipeline" and ...

GREENVILLE, S.C. (FOX Carolina) - A new medication is helping patients lower their cholesterol in a major way. For the first time, the treatment is available in a pill form. The once-daily tablet, ...

An estimated 21.5 million additional adults in the United States may now be eligible for statins under updated cholesterol treatment guidelines, according to a new study. The researchers aimed to ...

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown. By Gina Kolata The Food and Drug Administration approved a daily pill on Thursday ...

FDA approval establishes enlicitide as the first oral PCSK9 inhibitor for low-density lipoprotein cholesterol reduction, positioning it as a daily alternative to injectable PCSK9 agents. The approved ...